acarix Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory November 18, 2024 20 Mar 2024 Acarix announces the outcome of the exercise of warrants of series 2024:U1 (TO2) The Board of directors of Acarix AB ("Acarix" or the "Company") today announces the outcome of the exercise period for warrants of seri... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 19 Mar 2024 Acarix receives declarations of intent to exercise warrants of series TO 2 Acarix AB ("Acarix" or the "Company") has received oral declarations of intent to exercise Warrants of series TO 2 (the "Warrants") fro... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 15 Mar 2024 CEO purchases shares in Acarix New York, New York, March 15, 2024 – Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces that Aamir Mahmoo... Continue reading
acarix Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory November 18, 2024 06 Mar 2024 The exercise period for Acarix warrants of series 2024:U1 (TO2) begins today The exercise period for the warrants of series 2024:U1 (TO2) (the "Warrants") issued in connection with Acarix AB ("Acarix" or the "Com... Continue reading
acarix Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM November 18, 2024 21 Feb 2024 Announcement from Acarix’s extra general meeting The extra general meeting of Acarix AB (the "Company") was held today on 21 February 2024 and the following resolution was passed by th... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 15 Feb 2024 Acarix strengthens US Advisory Board with three industry leaders New York, New York, February 15, 2024 – Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the appointmen... Continue reading
acarix English, Interim, IR, Listing Regulation, News, Regulatory, Report, Yearend November 18, 2024 15 Feb 2024 Acarix AB (publ) publishes Year-End Report 2023 Embarking on a new journey with focus on sustainable growthAs the newly appointed CEO of Acarix, I am honored to be on board and share ... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 14 Feb 2024 Invitation to presentation of Acarix´s fourth quarter report Acarix will publish its fourth quarter results on Thursday 15 February 2024 at 08.00 am (CEST). A live webcast will be held at 15.00 (C... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 02 Feb 2024 Acarix CADScor System now listed on US Federal Supply Schedule Acarix, a leader in advanced acoustic and algorithm based cardiac diagnostic devices today announces that its CADScor System has been a... Continue reading
acarix Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory November 18, 2024 01 Feb 2024 NOTICE OF EXTRA GENERAL MEETING IN ACARIX AB The shareholders of Acarix AB, reg. no. 559009-0667 (the "Company"), are hereby invited to the extra general meeting on Wednesday 21 Fe... Continue reading
acarix Corporate Action, English, IR, Issuance, MAR, mfn-cus-disclaimer, News, Regulatory, Shares November 18, 2024 01 Feb 2024 Acarix carries out a directed share issue of approximately SEK 33.7 million THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BE... Continue reading
acarix Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory November 18, 2024 01 Feb 2024 Acarix appoints Aamir Mahmood as new CEO Stockholm, Sweden, Feb 1, 2024 - The Board of Acarix AB (publ) announces today the appointment of Aamir Mahmood as new CEO with immedia... Continue reading